BioGenerator
Funding rounds backed by BioGenerator.
- Funding disclosed in full
- $35M
- Median round
- $35M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Allotera Therapeutics Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies | $35MSeries C | BiotechUnited States |